Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 434-280-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
EC 434-280-4 was negative in an OECD 471 and 473 study.
In the OECD 471 study, the test material caused a visible reduction in the growth of the background lawn to all of the Salmonella tester strains, initially at 50 and 150 micro-grams per plate with and without S9 respectively. Toxicity was also observed tp Escherichia coli strain WP2uvrA-, initially at 50 and 500 micro-grams per plate with and without S9 respectivelt. The test material was, therefore, testted up to the toxic limit. An oily precipitate was observed at 5000 micro-grams plate only, this did not prevent the scoring of relevant colonie. No signficiant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, with or without metabolic activation. The test material was considereed to be non-mutagenic under the conditions of this test.
No OECD 476 data is available on EC 434-280-4. However, there is sufficient data on the dissociation products and the functional groups that comprise the final salt reaction product to conclude that there is no potential for mutagenicity in mammalian cells. The complete assessemnt can be found in the corresponding endpoint record.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
No premature deaths were observed in any of the dose groups. The clinical sign, hunched posture, was observed in animals dosed with test material at 18 mglkg in the 48-hour
dose group only. Statistically significant decreases in the PCE/NCE ratio were obsemed in the 24-hour 4.5 and 9 mgkg test material dose groups when compared to their concurrent control group. With no statistically significant decreases in the PCE/NCE ratio being observed in either of the two 18 mgkg dose groups the validity of the responses seen in the lower dose levels may be questioned. However, both of the 18 mgkg dose groups had PCE/NCE ratio values lower than their concurrent vehicle controls and, therefore, the decreases in PCE/NCE ratios were taken to indicate that exposure to the bone marrow had been achieved.
There was no evidence of a significant increase in the incidence af micronucleated polychromatic
erythrocytes in animals dosed with the test material when compared to the concurrent vehicIe
control groups.
The positive control group showed a marked and statistically significant increase in the incidence
of micronucleated polychromatic erythrocytes hence confirming the sensitivity of the system to
the known mutagenic activity of cyclophosphamide under the conditions of the test. However, it
should be noted that the sample of cyclophosphamide used proved to be very toxic, as indicated
by the NCE values and the significant reduction in the PCElNCE ratio value. This also led to two
animals (numbers 17 and 19) having very low individual score for micronucleated PCEs,
hawever, the overall response was considered adequate and not to affect the integrity of the study.
Conclusion:. The test material was considered to be non-genotoxic under the conditions of the
test.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
In vitro study
The test material caused a visible reduction in the growth of the background lawn to all of the Salmonella tester strains, initially at 50 and 150 micro-grams per plate with and without S9 respectively. Toxicity was also observed tp Escherichia coli strain WP2uvrA-, initially at 50 and 500 micro-grams per plate with and without S9 respectivelt. The test material was, therefore, testted up to the toxic limit. An oily precipitate was observed at 5000 micro-grams plate only, this did not prevent the scoring of relevant colonie.
No signficiant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, with or without metabolic activation.
In vivo study
No premature deaths were observed in any of the dose groups. The clinical sign, hunched posture, was observed in animals dosed with test material at 18 mglkg in the 48-hour
dose group only. Statistically significant decreases in the PCElNCE ratio were obsemed in the 24-hour 4.5 and 9 mgkg test material dose groups when compared to their concurrent control group. With no statistically significant decreases in the PCE/NCE ratio being observed in either of the two 18 mgkg dose groups the validity of the responses seen in the lower dose levels may be questioned. However, both of the 18 mgkg dose groups had PCE/NCE ratio values lower than their concurrent vehicle controls and, therefore, the decreases in PCE/NCE ratios were taken to indicate that exposure to the bone marrow had been achieved.
There was no evidence of a significant increase in the incidence af micronucleated polychromatic
erythrocytes in animals dosed with the test material when compared to the concurrent vehicIe
control groups.
The positive control group showed a marked and statistically significant increase in the incidence
of micronucleated polychromatic erythrocytes hence confirming the sensitivity of the system to
the known mutagenic activity of cyclophosphamide under the conditions of the test. However, it
should be noted that the sample of cyclophosphamide used proved to be very toxic, as indicated
by the NCE values and the significant reduction in the PCElNCE ratio value. This also led to two
animals (numbers 17 and 19) having very low individual score for micronucleated PCEs,
hawever, the overall response was considered adequate and not to affect the integrity of the study.
Conclusion:. The test material was considered to be non-genotoxic under the conditions of the
test.
The test material was considereed to be non-mutagenic under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.